These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 18712127

  • 1. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R, Köberlein J, Keppler J.
    MMW Fortschr Med; 2008 Jun 26; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract] [Full Text] [Related]

  • 2. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM, Eigenmann PA.
    J Allergy Clin Immunol; 2009 Aug 26; 124(2):378-9. PubMed ID: 19541352
    [No Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis.
    Sieber J, Köberlein J, Mösges R.
    Curr Med Res Opin; 2010 Apr 26; 26(4):925-32. PubMed ID: 20163297
    [Abstract] [Full Text] [Related]

  • 4. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
    Wise SK, Schlosser RJ.
    Otolaryngol Clin North Am; 2012 Oct 26; 45(5):1045-54. PubMed ID: 22980684
    [Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy and regulatory T cells.
    Ciprandi G, Fenoglio D, Cirillo I, Milanese M, Minuti P.
    Allergy; 2006 Apr 26; 61(4):511-3. PubMed ID: 16512819
    [No Abstract] [Full Text] [Related]

  • 6. Sublingual immunotherapy.
    Lin SY, Leatherman B.
    Otolaryngol Clin North Am; 2011 Jun 26; 44(3):753-64, x-xi. PubMed ID: 21621059
    [Abstract] [Full Text] [Related]

  • 7. Do indications to sublingual immunotherapy need to be revised?
    Incorvaia C, Mauro M.
    J Allergy Clin Immunol; 2010 Jan 26; 125(1):277; author reply 277-8. PubMed ID: 20109757
    [No Abstract] [Full Text] [Related]

  • 8. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
    Agostinis F, Tellarini L, Canonica GW, Falagiani P, Passalacqua G.
    Allergy; 2005 Jan 26; 60(1):133. PubMed ID: 15575951
    [No Abstract] [Full Text] [Related]

  • 9. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS.
    J Allergy Clin Immunol; 2009 Apr 26; 123(4):763-9. PubMed ID: 19217653
    [Abstract] [Full Text] [Related]

  • 10. Monoid sublingual immunotherapy.
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML.
    Eur Ann Allergy Clin Immunol; 2006 Mar 26; 38(3):87-9. PubMed ID: 16752693
    [Abstract] [Full Text] [Related]

  • 11. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW, Passalacqua G.
    Allergy; 2006 Mar 26; 61 Suppl 81():20-3. PubMed ID: 16792602
    [Abstract] [Full Text] [Related]

  • 12. Case reports by Cochard and Eigenmann.
    Thompson JC, Morris MS.
    J Allergy Clin Immunol; 2010 Jan 26; 125(1):277; author reply 277-8. PubMed ID: 20109758
    [No Abstract] [Full Text] [Related]

  • 13. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 14. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L, Wallace D.
    Immunol Allergy Clin North Am; 2011 Aug 02; 31(3):561-99. PubMed ID: 21737043
    [Abstract] [Full Text] [Related]

  • 15. [Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L, Lu JH, Xie Q, Wu YL, Zhu LP, Cheng L.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun 02; 45(6):444-9. PubMed ID: 21055319
    [Abstract] [Full Text] [Related]

  • 16. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T, Quarta C, Bruno ME, Falagiani P, Riva G.
    Eur Ann Allergy Clin Immunol; 2006 Nov 02; 38(9):310-2. PubMed ID: 17191751
    [Abstract] [Full Text] [Related]

  • 17. Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites.
    Roger A, Justicia JL, Navarro LÁ, Eseverri JL, Ferrès J, Malet A, Alvà V.
    Int Arch Allergy Immunol; 2011 Nov 02; 154(1):69-75. PubMed ID: 20664280
    [Abstract] [Full Text] [Related]

  • 18. Update on allergen immunotherapy for treatment of allergic diseases.
    Kwong KY, Leibel S.
    Adv Pediatr; 2013 Nov 02; 60(1):141-65. PubMed ID: 24007843
    [No Abstract] [Full Text] [Related]

  • 19. Allergen immunotherapy for allergic rhinitis.
    Okubo K, Gotoh M.
    J Nippon Med Sch; 2010 Dec 02; 77(6):285-9. PubMed ID: 21206140
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.